Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Tumor Lysate-pulsed DC-CIK in Colorectal Cancer
NCT02202928Phase 2Unknown
- Sponsor
- Shenzhen Hornetcorn Biotechnology Co., Ltd.
- Start
- Jul 2014
- Primary completion
- Dec 2017
- Modality
- Whole Cell Cancer Vaccines, Lymphokine-Activated Killer Cells, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor lysate-pulsed DC-CIK cells in colorectal cancer (CRC), sponsored by Shenzhen Hornetcorn Biotechnology Co., Ltd.. Status: unknown.
02
Drugs
autologous tumor lysate-pulsed DC-CIK cells
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02202928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202928.